Mechanism of action of brexpiprazole: Comparison with aripiprazole

CNS Spectrums

Volumn 21, Issue 1, 2013, Pages 1-6

  Stahl, Stephen M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; BIFEPRUNOX; BREXPIPRAZOLE; NEUROLEPTIC AGENT; NEUROTRANSMITTER RECEPTOR; SEROTONIN 1A ANTAGONIST; SEROTONIN 2A ANTAGONIST; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; QUINOLONE DERIVATIVE; SEROTONIN 1 AGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 2 ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN RECEPTOR AFFECTING AGENT; THIOPHENE DERIVATIVE;

ADD ON THERAPY; AGITATION; AKATHISIA; ARTICLE; BODY WEIGHT DISORDER; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG TOLERABILITY; HUMAN; INTRINSIC ACTIVITY; MAJOR DEPRESSION; PRIORITY JOURNAL; RECEPTOR BINDING; SCHIZOPHRENIA; WEIGHT GAIN; AGONISTS; DEPRESSIVE DISORDER, MAJOR; DRUG EFFECTS;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ANTIPSYCHOTIC AGENTS; ARIPIPRAZOLE; DEPRESSIVE DISORDER, MAJOR; DOPAMINE AGONISTS; HUMANS; QUINOLONES; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, DOPAMINE D2; SCHIZOPHRENIA; SEROTONIN 5-HT1 RECEPTOR AGONISTS; SEROTONIN 5-HT2 RECEPTOR ANTAGONISTS; SEROTONIN AGENTS; THIOPHENES;

EID: 84959338879     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852915000954     Document Type: Article

References (10)

1. Stahl SM. Stahl's Essential Psychopharmacology. 4th ed. Cambridge, UK: Cambridge University Press; 2013.
2. Mitzenberg MJ, Yoon JH. An index of relative central α-Adrenergic receptor antagonism by antipsychotic medications. Exp Clin Psychopharmacol. 2011; 19(1): 31-39.
3. Marek GJ, Aghahanian GK. 5-HT2A receptor or alpha1-Adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex. Eur J Pharmacol. 1999; 367(2-3): 197-206.
4. Marek GJ, Aghajanian GK. Alpha 1B-Adrenoceptor-mediated excitation of piriform cortical interneurons. Eur J Pharmacol. 1996; 305(1-3): 95-100.
5. Pudovkina OL, Cremers T, Westerink B. Regulation of the release of serotonin in the dorsal raphe nucleus by alpha1 and alpha2 adrenoceptors. Synapse. 2003; 50(1): 77-82.
6. Amargós-Bosch M, Adell A, Bortolozzi A, Artigas F. Stimulation of alpha1-Adrenoceptors in the rat medial prefrontal cortex increases the local in vivo 5-hydroxytryptamine release: reversal by antipsychotic drugs. J Neurochem. 2003; 87(4): 831-842.
7. Mitrano D, Schroeder JP, Smith Y, et al. α1 adrenergic receptors are localized on presynaptic elements in the nucleus accumbens and regulate mesolimbic dopamine transmission. Neuropsychopharmacology. 2012; 37(9): 2161-2172.
8. Coteccia S. The α1-Adrenergic receptors: diversity of signaling networks and regulation. J Recept Signal Transduct Res. 2010; 30(6): 410-419.
9. Stahl SM. Role of α1 adrenergic antagonism in the mechanism of action of iloperidone: reducing extrapyramidal side effects. CNS Spectr. 2013; 18(6): 285-288.
10. Citrome L. The ABC's of dopamine receptor partial agonists-aripiprazole, brexpiprazole and cariprazine: the 15-min challenge to sort these agents out. Int J Clin Pract. 2015; 69(11): 1211-1220.